phenytoin and pc-796
phenytoin has been researched along with pc-796 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Fujioka, H; Kishi, M; Masuda, Y; Miyazaki, H; Tan, T; Yokoyama, Y | 1 |
| Fujioka, H; Tan, T | 1 |
Other Studies
2 other study(ies) available for phenytoin and pc-796
| Article | Year |
|---|---|
Biopharmaceutical studies on hydantoin derivatives. V. Pharmacokinetics and pharmacodynamics of 5,5-diphenylhydantoin and 1-benzenesulfonyl-5,5-diphenylhydantoin.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Anticonvulsants; Brain; Dinoprostone; Injections, Intravenous; Injections, Intraventricular; Liver; Male; Mephenytoin; Mice; Phenytoin; Prostaglandins E; Protein Binding; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
Biopharmaceutical studies on hydantoin derivatives. III. Physico-chemical properties, dissolution behavior, and bioavailability of the molecular compound of 1-benzenesulfonyl-5,5-diphenylhydantoin and antipyrine.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Biological Availability; Chemical Phenomena; Chemistry; Dogs; Drug Combinations; Intestinal Absorption; Male; Phenytoin; Solubility | 1982 |